Doctors' views on hidden inflammation in heart and kidney patients surveyed
NCT ID NCT06589791
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveyed 1,500 Chinese heart and kidney specialists to understand their awareness and perceptions of systemic inflammation in patients with both atherosclerotic cardiovascular disease and chronic kidney disease. The goal was to learn how doctors currently identify and manage inflammation in these patients. No treatments were tested; it was purely a knowledge-gathering survey.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novo Nordisk Shanghai Pharmaceuticals Co., Ltd
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Plastics in dialysis: could they add toxins to Children's blood?
- Can a newer heart failure drug protect kidneys better than an older one?
- A urine test strip that could transform kidney diet care?
- Can a drop of blood predict disease years before it strikes?
- Can a Home-Based program help kidney patients get stronger before transplant?
- Immune cell study may unlock kidney protection in type 1 diabetes